top of page

Hello
Viviana Cetola
Argentinian


FDA Approves New Pill That Reduces Bad Cholesterol by Nearly 60%
Viviana Cetola Life News Today A new option for the treatment of high cholesterol has just marked an important advance in cardiology. The United States Food and Drug Administration (FDA) approved Lipfendra (enlicitide), the first PCSK9 inhibitor that can be taken orally. In clinical studies, the medication achieved reductions in LDL cholesterol of nearly 60%. Cholesterol is a waxy, fat-like substance found in all the cells of the body. The human body needs some cholestero

Viviana Cetola
Sep 1


Experimental Vaccine Aims to Prevent Lung Cancer
Viviana Cetola Reporter, Life News Today For the first time, an experimental vaccine designed to prevent lung cancer is being evaluated in a clinical trial in humans. LungVax, developed by researchers at the University of Oxford and University College London, is initially intended for people who are at an increased risk of developing the disease. The project represents a novel approach in the fight against one of the deadliest types of cancer because, rather than treating a

Viviana Cetola
Aug 20


2025 Nobel Prize Could Transform Cancer and Autoimmune Care
Viviana Cetola Reporter, Life News Today The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell of the United States and Shimon Sakaguchi of Japan for discoveries that revealed how the immune system prevents itself from attacking the body it is designed to protect. The Nobel Assembly at Sweden's Karolinska Institute recognized the three scientists for their pioneering research on peripheral immune tolerance and regulatory T cells,

Viviana Cetola
Jul 23


FDA Approves Use of Eye Drops that Eliminate the Use of Glasses
By Viviana Cetola Reporter, Life News Today The U.S. Food and Drug Administration (FDA) has approved Vizz (aceclidine ophthalmic solution 1.44%) for the treatment of presbyopia in adults. What is presbyopia? If you are over 40 years old and experience blurry vision, especially up close, there is a possibility that it is presbyopia. It is, in fact, the first result when you get when you Google "I see a little blurry", but we emphasize again that this search engine is not a

Viviana Cetola
Jul 19


Magnetic Resonance Guided Cryoablation
By Viviana Cetola Life News Today Recently, Liverpool Hospital in south-east Sydney has introduced Australia's first dedicated MRI-guided cryoablation system. A new MRI machine guides a probe that releases cold gas and destroys tumors, freezing them without any surgical incisions. The procedure, pioneered by interventional radiologist Dr. Glen Schlaphoff, is also known as cryosurgery or cryotherapy and is minimally invasive. It uses specialized 17-gauge needles inserted d

Viviana Cetola
Jul 19


Immune reset, the new strategy for therapies for autoimmune disorders
By Viviana Cetola Reporter, Life News Today Dr John Isaacs, from Newcastle University, published a paper in Nature Reviews Rheumatology in which he discussed the groundbreaking concept that promises to revolutionise science: the immune reset. This was published on his X account by the prestigious cardiologist and science communicator, Eric Topol, who described it as the possibility of "restarting the immune system by eliminating B cells, it is like restarting a computer, to

Viviana Cetola
Feb 26


FDA clears new robotic surgery system, expanding options for prostate and kidney procedures
FDA clears new robotic surgery system, expanding options for prostate and kidney procedures

Viviana Cetola
Feb 19


Acuerdo Comercial Mercosur–Unión Europea
By Viviana Cetola Life News Today, Reporter The Southern Common Market (Mercosur) and the European Union (EU) signed an association agreement Jan. 17, 2026, presenting it as the culmination of nearly 25 years of negotiations and a major step toward reshaping trade and political ties between South America and Europe. According to explanatory materials published by Paraguay’s Ministry of Foreign Affairs, the agreement links markets representing about 700 million people and a co

Viviana Cetola
Jan 25


Science’s Long March Toward Healing: How Two Experimental Compounds Could Rewrite the Story of Multiple Sclerosis
By Viviana Cetola With Life News Today — October 2025 For generations, multiple sclerosis has been a disease of frustration, a slow unraveling of the nervous system where the body turns against itself. But in two university labs separated by 1,700 miles, a pair of molecules may be writing a new chapter in how we think about healing. At the University of California, Riverside, neuroscientist Seema Tiwari-Woodruff and her team have spent years asking one question: Can damaged n

Viviana Cetola
Oct 16, 2025
Contact
I'm always looking for new and exciting opportunities. Let's connect.
123-456-7890
bottom of page
